A randomized, double-blind, parallel group study to compare the 7-day gastrointestinal safety of 2 doses of PLA-695 [giripladib] to that of placebo and naproxen
Latest Information Update: 24 Jul 2007
At a glance
- Drugs Giripladib (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Wyeth
- 03 Dec 2006 New trial record.